Activation of sympathetic nerves, NE administration, and β-adrenergic receptor (β-AR) excitation have been shown to impair anti-tumor immune responses within LNs by reducing the motility of T cells, B cells, and antigen-presenting cells (APCs), as well as inducing vasoconstriction (35). Here, ADRB2 is linked to neoplasm.